Xiaoli Mu

630 total citations
38 papers, 478 citations indexed

About

Xiaoli Mu is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Xiaoli Mu has authored 38 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Xiaoli Mu's work include Head and Neck Cancer Studies (8 papers), Head and Neck Surgical Oncology (5 papers) and Reproductive Biology and Fertility (3 papers). Xiaoli Mu is often cited by papers focused on Head and Neck Cancer Studies (8 papers), Head and Neck Surgical Oncology (5 papers) and Reproductive Biology and Fertility (3 papers). Xiaoli Mu collaborates with scholars based in China, United Kingdom and United States. Xiaoli Mu's co-authors include Meiping Tian, Qingyu Huang, Heqing Shen, Jie Zhang, Liangpo Liu, Francis L. Martin, Xiaoxue Wang, Yankai Xia, Jingjing Wang and Ling He and has published in prestigious journals such as SHILAP Revista de lepidopterología, Environmental Science & Technology and The Science of The Total Environment.

In The Last Decade

Xiaoli Mu

35 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoli Mu China 12 154 151 137 58 52 38 478
Daniel N. Johnson United States 13 46 0.3× 266 1.8× 191 1.4× 68 1.2× 168 3.2× 38 811
Chien-Jen Chen Taiwan 7 104 0.7× 71 0.5× 101 0.7× 103 1.8× 61 1.2× 8 449
Johnny Shinn Nan Lin Taiwan 11 241 1.6× 209 1.4× 252 1.8× 81 1.4× 122 2.3× 15 688
Nancy M. Hanley United States 13 46 0.3× 270 1.8× 144 1.1× 32 0.6× 27 0.5× 22 491
Arlette Michaux Belgium 17 30 0.2× 107 0.7× 326 2.4× 107 1.8× 18 0.3× 27 857
Michael G. Chen United States 14 49 0.3× 129 0.9× 415 3.0× 176 3.0× 82 1.6× 25 930
Xiaoqiang Qiu China 19 136 0.9× 337 2.2× 319 2.3× 72 1.2× 38 0.7× 95 997
Takayuki Watanabe Japan 18 217 1.4× 174 1.2× 220 1.6× 166 2.9× 569 10.9× 72 1.3k
Hua Xu China 11 61 0.4× 108 0.7× 72 0.5× 36 0.6× 68 1.3× 31 366
José Expósito Spain 15 27 0.2× 471 3.1× 366 2.7× 171 2.9× 33 0.6× 40 1.1k

Countries citing papers authored by Xiaoli Mu

Since Specialization
Citations

This map shows the geographic impact of Xiaoli Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Mu more than expected).

Fields of papers citing papers by Xiaoli Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Mu. The network helps show where Xiaoli Mu may publish in the future.

Co-authorship network of co-authors of Xiaoli Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Mu. A scholar is included among the top collaborators of Xiaoli Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Mu. Xiaoli Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Zhu, Yajuan, Jiaxiang Wang, Xiaoli Mu, et al.. (2023). Personalised neoantigen‐based therapy in colorectal cancer. Clinical and Translational Medicine. 13(11). e1461–e1461. 12 indexed citations
4.
5.
Du, Yang, Yajuan Zhu, Bo Zeng, Xiaoli Mu, & Jiyan Liu. (2022). Super-Resolution Quantification of T2DM-Induced Mitochondrial Morphology Changes and Their Implications in Pharmacodynamics of Metformin and Sorafenib. Frontiers in Pharmacology. 13. 932116–932116. 5 indexed citations
6.
Hu, Xiaolin, Yan He, Hui Guan, et al.. (2021). Clinical and survival analysis of nasopharyngeal carcinoma with consistently negative Epstein–Barr virus DNA. Head & Neck. 43(5). 1465–1475. 7 indexed citations
7.
Liu, Zheran, Jianjun Ren, Juejin Li, et al.. (2021). Association between fish oil supplementation and cancer risk according to fatty fish consumption: A large prospective population‐based cohort study using UK Biobank. International Journal of Cancer. 150(4). 562–571. 13 indexed citations
8.
He, Yan, Zhihao Zhao, Ying Wang, et al.. (2021). Induction chemotherapy followed by intensity‐modulated radiotherapy versus concurrent chemoradiotherapy in nasopharyngeal carcinoma: A retrospective analysis. Clinical Otolaryngology. 46(5). 976–982. 7 indexed citations
9.
Guan, Hui, Yan He, Yonglin Su, et al.. (2021). Assessment of different induction chemotherapy regimens in locally advanced nasopharyngeal carcinoma: Meta‐analysis. Head & Neck. 43(8). 2332–2341. 4 indexed citations
10.
Li, Ruidan, Zhigong Wei, Zheran Liu, et al.. (2021). The prognostic role of radiotherapy and radiotherapy target in cervical lymph node metastatic squamous cell carcinoma with unknown primary: a retrospective study. Journal of Cancer Research and Clinical Oncology. 148(6). 1437–1445. 1 indexed citations
11.
Liu, Zheran, Ye Chen, Zhigong Wei, et al.. (2021). Comparative efficacy and safety of immunotherapy in the first-line treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis. Annals of Palliative Medicine. 10(3). 2805–2814. 6 indexed citations
12.
He, Ling, Jianghong Xiao, Zhigong Wei, et al.. (2020). Toxicity and dosimetric analysis of nasopharyngeal carcinoma patients undergoing radiotherapy with IMRT or VMAT: A regional center's experience. Oral Oncology. 109. 104978–104978. 13 indexed citations
13.
Wang, Jingjing, Ping Ai, Yan He, et al.. (2020). Observation versus radiotherapy with or without temozolomide in postoperative WHO grade II high-risk low-grade glioma: a retrospective cohort study. Neurosurgical Review. 44(3). 1447–1455. 14 indexed citations
14.
He, Yan, Jialing He, Jingjing Wang, et al.. (2020). Optimizing number of cycles of induction chemotherapy for patients with nasopharyngeal carcinoma: Retrospective survival analysis. Head & Neck. 42(8). 2067–2076. 19 indexed citations
15.
Mu, Xiaoli, Ling He, Hui Guan, et al.. (2020). Prognostic nomogram for adenoid cystic carcinoma in different anatomic sites. Head & Neck. 43(1). 48–59. 19 indexed citations
16.
17.
18.
Mu, Xiaoli, Jie Zhang, Siyuan Peng, Xiaoxue Wang, & Heqing Shen. (2014). Simultaneous analysis of global DNA methylation and hydroxymethylation in tissues by liquid chromatography-tandem mass spectrometry. Chinese Journal of Chromatography. 32(7). 682–682. 1 indexed citations
19.
Zhang, Jie, Heqing Shen, Weipan Xu, et al.. (2014). Urinary Metabolomics Revealed Arsenic Internal Dose-Related Metabolic Alterations: A Proof-of-Concept Study in a Chinese Male Cohort. Environmental Science & Technology. 48(20). 12265–12274. 73 indexed citations
20.
Mu, Xiaoli. (2007). Culture method of the myocardial cell in Neonate Rats. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel N. Johnson Breakdown of academic impact, for papers by Chien-Jen Chen Breakdown of academic impact, for papers by Johnny Shinn Nan Lin Breakdown of academic impact, for papers by Nancy M. Hanley Breakdown of academic impact, for papers by Arlette Michaux Breakdown of academic impact, for papers by Michael G. Chen Breakdown of academic impact, for papers by Xiaoqiang Qiu Breakdown of academic impact, for papers by Takayuki Watanabe Breakdown of academic impact, for papers by Hua Xu Breakdown of academic impact, for papers by José Expósito
Rankless by CCL
2026